The DEXLIFE study methods: Identifying novel candidate biomarkers that predict progression to type 2 diabetes in high risk individuals

Diabetes Research and Clinical Practice

Volumn 106, Issue 2, 2014, Pages 383-389

  Andersen, G S ^a   Thybo, T ^a   Cederberg, H ^b   Oresic M ^a   Esteller, M ^c   Zorzano, A ^d,e,f   Carr, B ^g   Walker, M ^h   Cobb, J ⁱ   Clissmann, C ^j   O'Gorman, D J ^k   Nolan, J J ^a  

^a STENO DIABETES CENTER   (Denmark)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^d INSTITUTE FOR RESEARCH IN BIOMEDICINE   (Spain)

^e UNIVERSITY OF BARCELONA   (Spain)

^f INSTITUTO DE SALUD CARLOS III   (Spain)

^g Voluntary Health Insurance Ltd   (Ireland)

^h NEWCASTLE UNIVERSITY   (United Kingdom)

ⁱ METABOLON INC   (United States)

^j DUBLIN CITY COUNCIL   (Ireland)

^k DUBLIN CITY UNIVERSITY   (Ireland)

more..

Author keywords

Biomarkers; Lifestyle intervention; Prevention; Type 2 diabetes

Indexed keywords

CERAMIDE; CHOLESTEROL ESTER; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; SPHINGOMYELIN; TRANSCRIPTOME; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

ACCELEROMETRY; ADULT; AEROBIC CAPACITY; AGED; ARTICLE; BODY COMPOSITION; CONTROLLED STUDY; DISEASE COURSE; EPIGENETICS; FEMALE; GLUCOSE INTOLERANCE; HEART RATE VARIABILITY; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPIDOMICS; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; MUSCLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; PHENOTYPE; PHYSICAL ACTIVITY; PREDICTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; DIABETES MELLITUS, TYPE 2; DIET THERAPY; KINESIOTHERAPY; LIFESTYLE; MIDDLE AGED; PATHOLOGY; PREDIABETIC STATE; PROGNOSIS; RISK FACTOR; RISK REDUCTION;

ADULT; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COHORT STUDIES; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DISEASE PROGRESSION; EXERCISE THERAPY; FEMALE; GLUCOSE INTOLERANCE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; PREDIABETIC STATE; PROGNOSIS; RISK FACTORS; RISK REDUCTION BEHAVIOR; YOUNG ADULT;

EID: 84920662680     PISSN: 01688227     EISSN: 18728227     Source Type: Journal    
DOI: 10.1016/j.diabres.2014.07.025     Document Type: Article

References (18)

1. International Diabetes Federation IDF diabetes atlas 2013, International Diabetes Federation, Brussels, Belgium. 6th ed.
2. Bonora E., Tuomilehto J. The pros and cons of diagnosing diabetes with A1C. Diabetes Care 2011, 34:S184-S190.
3. Zhuo X., Zhang P., Selvin E., Hoerger T.J., Ackermann R.T., Li R., et al. Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention: a cost-effectiveness perspective. Am J Prev Med 2012, 42:374-381.
4. American Diabetes Association Diagnosis and classification of diabetes mellitus. Diabetes Care 2010, 33(Suppl. 1):S62-S69.
5. Committee T.I.E. International Expert Committee Report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 2009, 32:1327-1334.
6. Færch K., Witte D.R., Tabák A.G., Perreault L., Herder C., Brunner E.J., et al. Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes Endocrinol 2013.
7. Stancáková A., Javorský M., Kuulasmaa T., Haffner S.M., Kuusisto J., Laakso M. Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men. Diabetes 2009, 58:1212-1221.
8. Hills S.A., Balkau B., Coppack S.W., Dekker J.M., Mari A., Natali A., et al. The EGIR-RISC STUDY (The European group for the study of insulin resistance: relationship between insulin sensitivity and cardiovascular disease risk): I. Methodology and objectives. Diabetologia 2004, 47:566-570.
9. Lindström J., Louheranta A., Mannelin M., Rastas M., Salminen V., Eriksson J., et al. The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity. Diabetes Care 2003, 26:3230-3236.
10. Lindström J., Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003, 26:725-731.
11. Evans A.M., DeHaven C.D., Barrett T., Mitchell M., Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 2009, 81:6656-6667.
12. Ohta T., Masutomi N., Tsutsui N., Sakairi T., Mitchell M., Milburn M.V., et al. Untargeted metabolomic profiling as an evaluative tool of fenofibrate-induced toxicology in Fischer 344 male rats. Toxicol Pathol 2009, 37:521-535.
13. Dehaven C.D., Evans A.M., Dai H., Lawton K.A. Organization of GC/MS and LC/MS metabolomics data into chemical libraries. J Cheminform 2010, 2:9.
14. Nygren H., Seppänen-Laakso T., Castillo S., Hyötyläinen T., Orešič M. Liquid chromatography-mass spectrometry (LC-MS)-based lipidomics for studies of body fluids and tissues. Methods Mol Biol Clifton N J 2011, 708:247-257.
15. Pluskal T., Castillo S., Villar-Briones A. Oresic M. MZmine 2: modular framework for processing, visualizing, and analyzing mass spectrometry-based molecular profile data. BMC Bioinform 2010, 11:395.
16. Irizarry R.A., Bolstad B.M., Collin F., Cope L.M., Hobbs B., Speed T.P. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 2003, 31:e15.
17. Pietiläinen K.H., Róg T., Seppänen-Laakso T., Virtue S., Gopalacharyulu P., Tang J., et al. Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol 2011, 9:e1000623.
18. Orešič M., Tang J., Seppänen-Laakso T., Mattila I., Saarni S.E., Saarni S.I., et al. Metabolome in schizophrenia and other psychotic disorders: a general population-based study. Genome Med 2011, 3:19.